Infiltration of CD163-positive cells increased 2.7× in recurrent GBM specimens from patients treated with immunotherapy, although a 1.1× increase was observed in a pair of specimens from GBM patients treated with only standard therapy. Here, CD163 is linked to glioblastoma.